Description: | Dimethyl ((R)-4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)aspartate is an intermediate in the synthesis of (R)-Sitagliptin rac-Fumarate Adduct (S491040) which is an impurity of Sitagliptin (S491000), a trizolopyrazine dipeptidyl peptidase IV inhibitor. Sitagliptin has recently been approved for the therapy of type II diabetes. |
Molecular Weight: | 551.45 |
Molecular Formula: | C22H23F6N5O5 |
References: | Kim, D., et al. J. Med. Chem. 48, 141 (2005), Ahren, B., et al. Eur. J. Pharmacol. 521 164 (2005), Bergman, A., et al: Clin. Ther. 28, 55 (2006). |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-2-naphthalenesulfonamide
Copyright © 2025 BOC Sciences. All rights reserved.
Our Products